582 related articles for article (PubMed ID: 30635059)
1. GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells.
McGrath M; Tam E; Sladkova M; AlManaie A; Zimmer M; de Peppo GM
Stem Cell Res Ther; 2019 Jan; 10(1):11. PubMed ID: 30635059
[TBL] [Abstract][Full Text] [Related]
2. GMP-Compatible, Xeno-Free Culture of Human Induced Mesenchymal Stem Cells.
de Peppo GM
Methods Mol Biol; 2021; 2286():121-129. PubMed ID: 33381853
[TBL] [Abstract][Full Text] [Related]
3. The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells.
Czapla J; Matuszczak S; Kulik K; Wiśniewska E; Pilny E; Jarosz-Biej M; Smolarczyk R; Sirek T; Zembala MO; Zembala M; Szala S; Cichoń T
Stem Cell Res Ther; 2019 Aug; 10(1):235. PubMed ID: 31383013
[TBL] [Abstract][Full Text] [Related]
4. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells.
Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S
Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the use of a pharmaceutical grade xeno-free medium for in vitro expansion of human mesenchymal stem/stromal cells.
Cimino M; Gonçalves RM; Bauman E; Barroso-Vilares M; Logarinho E; Barrias CC; Martins MCL
J Tissue Eng Regen Med; 2018 Mar; 12(3):e1785-e1795. PubMed ID: 29024519
[TBL] [Abstract][Full Text] [Related]
7. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.
Chen YS; Pelekanos RA; Ellis RL; Horne R; Wolvetang EJ; Fisk NM
Stem Cells Transl Med; 2012 Feb; 1(2):83-95. PubMed ID: 23197756
[TBL] [Abstract][Full Text] [Related]
8. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.
Rajala K; Lindroos B; Hussein SM; Lappalainen RS; Pekkanen-Mattila M; Inzunza J; Rozell B; Miettinen S; Narkilahti S; Kerkelä E; Aalto-Setälä K; Otonkoski T; Suuronen R; Hovatta O; Skottman H
PLoS One; 2010 Apr; 5(4):e10246. PubMed ID: 20419109
[TBL] [Abstract][Full Text] [Related]
9. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Chase LG; Yang S; Zachar V; Yang Z; Lakshmipathy U; Bradford J; Boucher SE; Vemuri MC
Stem Cells Transl Med; 2012 Oct; 1(10):750-8. PubMed ID: 23197667
[TBL] [Abstract][Full Text] [Related]
11. Manufacturing Parameters for the Creation of Clinical-Grade Human-Induced Pluripotent Stem Cell Lines From Umbilical Cord Mesenchymal Stromal Cells.
Beckenkamp LR; da Silva CG; Von Hohendorff MLI; Ogliari KS
Stem Cells Transl Med; 2024 May; 13(5):454-461. PubMed ID: 38402590
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies.
Phermthai T; Thongbopit S; Pokathikorn P; Wichitwiengrat S; Julavijitphong S; Tirawanchai N
Cytotherapy; 2017 Aug; 19(8):990-1001. PubMed ID: 28566211
[TBL] [Abstract][Full Text] [Related]
13. Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells.
Barro L; Nebie O; Chen MS; Wu YW; Koh MB; Knutson F; Watanabe N; Takahara M; Burnouf T
Cytotherapy; 2020 Aug; 22(8):458-472. PubMed ID: 32536505
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
[TBL] [Abstract][Full Text] [Related]
16. Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application.
Bui HTH; Nguyen LT; Than UTT
Tissue Eng Regen Med; 2021 Feb; 18(1):15-23. PubMed ID: 33150562
[TBL] [Abstract][Full Text] [Related]
17. Xeno-Free Extraction, Culture, and Cryopreservation of Human Adipose-Derived Mesenchymal Stem Cells.
Escobar CH; Chaparro O
Stem Cells Transl Med; 2016 Mar; 5(3):358-65. PubMed ID: 26838269
[TBL] [Abstract][Full Text] [Related]
18. Xeno-free culture of human pluripotent stem cells.
Bergström R; Ström S; Holm F; Feki A; Hovatta O
Methods Mol Biol; 2011; 767():125-36. PubMed ID: 21822871
[TBL] [Abstract][Full Text] [Related]
19. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
[TBL] [Abstract][Full Text] [Related]
20. Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media.
Oikonomopoulos A; van Deen WK; Manansala AR; Lacey PN; Tomakili TA; Ziman A; Hommes DW
Sci Rep; 2015 Nov; 5():16570. PubMed ID: 26564250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
